A First-in-human Study to Investigate Single Doses of DCY636 in Healthy Volunteers and Multiple Doses in Participants With Moderate to Severe Atopic Dermatitis
Clinical trial NCT07604324 · RECRUITING
Trial details
- NCT number
- NCT07604324
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-02
- Primary completion
- 2028-01-27
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.